Stonebridge Capital Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Stonebridge Capital Advisors’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,532	Closed	-$35.3K	–	719
2023 Q3	$35.3K	Hold	2,532	–	–	﹤0.01%	407
2023 Q2	$29.8K	Hold	2,532	–	–	﹤0.01%	437
2023 Q1	$29.1K	Hold	2,532	–	–	﹤0.01%	454
2022 Q4	$31.5K	Sell	2,532 -36	-1%	-$459	﹤0.01%	418
2022 Q3	$34K	Buy	2,568 +36	+1%	+$532	﹤0.01%	391
2022 Q2	$35K	Hold	2,532	–	–	﹤0.01%	406
2022 Q1	$38K	Hold	2,532	–	–	﹤0.01%	429
2021 Q4	$34K	Hold	2,532	–	–	﹤0.01%	429
2021 Q3	$37K	Sell	2,532 -2,532	-50%	-$42.8K	﹤0.01%	389
2021 Q2	$90K	Buy	5,064 +2,532	+100%	+$45.1K	0.01%	363
2021 Q1	$44K	Buy	+2,532	New	+$44.5K	0.01%	365
2020 Q3	–	Sell	-2,504	Closed	-$36K	–	601
2020 Q2	$36K	Hold	2,504	–	–	0.01%	320
2020 Q1	$27K	Hold	2,504	–	–	0.01%	343
2019 Q4	$53K	Hold	2,504	–	–	0.01%	317
2019 Q3	$57K	Sell	2,504 -239	-9%	-$5.1K	0.01%	303
2019 Q2	$54K	Buy	+2,743	New	+$53.4K	0.01%	312

Other funds holding SBRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Stonebridge Capital Advisors's SBRA Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 2,532 shares — an estimated $35.3K sold.

Stonebridge Capital Advisors first reported a position in SBRA in Q2 2019 and held it in 16 quarters. The position peaked at $90K in Q2 2021. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 2,532 Sabra Healthcare REIT shares in Q4 2023, an estimated $35.3K.
Stonebridge Capital Advisors first reported a position in Sabra Healthcare REIT in Q2 2019 and held it in 16 quarters.
Stonebridge Capital Advisors's Sabra Healthcare REIT position peaked at $90K in Q2 2021.
359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.